163 related articles for article (PubMed ID: 37216745)
21. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.
Kandalam MM; Beta M; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266
[TBL] [Abstract][Full Text] [Related]
22. Variability in retinoblastoma genome stability is driven by age and not heritability.
Polski A; Xu L; Prabakar RK; Gai X; Kim JW; Shah R; Jubran R; Kuhn P; Cobrinik D; Hicks J; Berry JL
Genes Chromosomes Cancer; 2020 Oct; 59(10):584-590. PubMed ID: 32390242
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of mutations in the
Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
[TBL] [Abstract][Full Text] [Related]
24. Serum exosomal miRNA as biomarkers for Retinoblastoma.
Ravishankar H; Mangani AS; Phoebe Moses GL; Mani SP; Parameswaran S; Khetan V; Ganesan S; Krishnakumar S
Exp Eye Res; 2020 Oct; 199():108184. PubMed ID: 32795526
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology of retinoblastoma.
Sábado Alvarez C
Clin Transl Oncol; 2008 Jul; 10(7):389-94. PubMed ID: 18628066
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.
Wu S; Ai N; Liu Q; Zhang J
Oncol Rep; 2018 May; 39(5):2402-2412. PubMed ID: 29517104
[TBL] [Abstract][Full Text] [Related]
27. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.
Guo L; Bai Y; Ni T; Li Y; Cao R; Ji S; Li S
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34036380
[TBL] [Abstract][Full Text] [Related]
29. [Retinoblastoma update].
Aerts I; Lumbroso-Le Rouic L; Gauthier-Villars M; Brisse H; Doz F
Arch Pediatr; 2016 Jan; 23(1):112-6. PubMed ID: 26679524
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of RB1 mutations identified in 403 retinoblastoma patients.
Price EA; Price K; Kolkiewicz K; Hack S; Reddy MA; Hungerford JL; Kingston JE; Onadim Z
J Med Genet; 2014 Mar; 51(3):208-14. PubMed ID: 24225018
[TBL] [Abstract][Full Text] [Related]
31. Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.
Singh J; Mishra A; Pandian AJ; Mallipatna AC; Khetan V; Sripriya S; Kapoor S; Agarwal S; Sankaran S; Katragadda S; Veeramachaneni V; Hariharan R; Subramanian K; Mannan AU
Mol Vis; 2016; 22():1036-47. PubMed ID: 27582626
[TBL] [Abstract][Full Text] [Related]
32. Role of circular RNAs in retinoblastoma.
Li F; Yin YK; Zhang JT; Gong HP; Hao XD
Funct Integr Genomics; 2022 Dec; 23(1):13. PubMed ID: 36547723
[TBL] [Abstract][Full Text] [Related]
33. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.
Golabchi K; Soleimani-Jelodar R; Aghadoost N; Momeni F; Moridikia A; Nahand JS; Masoudifar A; Razmjoo H; Mirzaei H
J Cell Physiol; 2018 Apr; 233(4):3016-3023. PubMed ID: 28657205
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
[TBL] [Abstract][Full Text] [Related]
36. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
[TBL] [Abstract][Full Text] [Related]
37. Retinoblastoma.
Aerts I; Lumbroso-Le Rouic L; Gauthier-Villars M; Brisse H; Doz F; Desjardins L
Orphanet J Rare Dis; 2006 Aug; 1():31. PubMed ID: 16934146
[TBL] [Abstract][Full Text] [Related]
38. Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma.
Amare Kadam PS; Ghule P; Jose J; Bamne M; Kurkure P; Banavali S; Sarin R; Advani S
Cancer Genet Cytogenet; 2004 Apr; 150(1):33-43. PubMed ID: 15041221
[TBL] [Abstract][Full Text] [Related]
39. Genetic perspective of retinoblastoma: From present to future.
Jagadeesan M; Khetan V; Mallipatna A
Indian J Ophthalmol; 2016 May; 64(5):332-6. PubMed ID: 27380971
[TBL] [Abstract][Full Text] [Related]
40. Retinoblastoma and tumor-suppressor gene therapy.
Xu HJ
Ophthalmol Clin North Am; 2003 Dec; 16(4):621-9. PubMed ID: 14741002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
